Correction to: Bone Researchhttps://www.nature.com/articles/s41413-018-0029-4, published online 11 September 2018

During a re-read of our article [1], previously published in Bone Research, we noticed that Fig. 3b (second panel of line 4), which presented LAP2β immunostaining of first-passage MSCs from Alpl+/− mice at 4 months, was consistent to Fig. 7a (fourth panel of line 2), which was presented the LAP2β immunostaining of HPP MSCs. All the authors agree to rectify this mistake by rearranging Fig. 7 below.

Fig. 7: Alpl also controls the differentiation and senescence of human MSCs via ATP-mediated inactivation of the AMPKα pathway.
figure 7

a SA-β-gal staining and Ki67, γH2AX and LAP2β immunostaining of third-passage MSCs from normal controls and HPP patients. Quantification of Ki67+, γH2AX+ and LAP2β+ is indicated in the right panel. Scale bars: 50 μm. b Expression levels of ageing-specific genes in normal and HPP yiMSCs were examined by western blotting. Scale bars, 50 μm. c Expression levels of CD73 and CD39 in normal and HPP MSCs were examined by western blotting. d Extracellular ATP concentrations in normal and HPP MSC medium were examined by a regular ATP concentration assay. e Intracellular radioactivity was examined after a 1-h treatment with ATP-γ-32P in different lentiviral vector transduction groups. f Intracellular ATP concentrations were assayed 48 h after the transduction of different lentiviral vectors. g Western blotting analysis of p-AMPKα expression in normal control and the ALPL shRNA, HPP control and pLenti-ALPL groups. h Expression levels of p16 and p53 were assayed 48 h after the transduction of different lentiviral vectors. i HPP MSCs overexpressing ALPL or treatment with 0.1 mmol·L−1 metformin, Alizarin Red staining and quantification of mineralized nodules were performed on day 28 after osteogenic induction (OS). Expression levels of Runx2 and OCN were examined by western blotting on day 7 after induction. j Oil Red O staining and quantification of fat depots were performed on day 14 after the adipogenic induction (AD). PPAR-γ expression was examined on day 7 after induction by western blotting. Scale bars, 100 μm. (N) Normal control n = 5, HPP (hypophosphatasia patient) n = 2. The data are presented as the means ± s.d. of each independent experiment performed in triplicate. *P < 0.05, **P < 0.01. e–f, i–j One-way analysis of variance (ANOVA). a, d Unpaired two-tailed Student’s t-test.

Full size image

This correction does not affect the results or conclusions of the above paper. We apologize for this typographical error and any inconvenience caused.